Diagnostics Co. Shorted Workers On Stock Options, Suit Claims

Law360, Wilmington (November 15, 2012, 9:30 PM EST) -- A former Caris Life Sciences Inc. employee launched a class action in Delaware on Wednesday alleging the cancer diagnostics company shortchanged employees when it repurchased their stock options prior to merging with a Japanese firm last year.

The $5.07-per-share price Dallas-based Caris paid did not properly account for the value of two promising business segments Caris spun off before most of the company and its employees were shipped to Japan’s Miraca Holdings Inc. in a $725 million deal last fall, according to a complaint ex-employee Kurt...
To view the full article, register now.